Background Non-steroidal anti-inflammatory drugs (NSAIDs) are a common cause of adverse drug events (ADEs), but renal risks of NSAIDs are less well quantified than …
B Bowe, Y Xie, E Xu, Z Al-Aly - Journal of the American Society of …, 2021 - journals.lww.com
Background COVID-19 is associated with increased risk of post-acute sequelae involving pulmonary and extrapulmonary organ systems—referred to as long COVID. However, a …
B Bowe, M Cai, Y Xie, AK Gibson… - Clinical Journal of the …, 2021 - journals.lww.com
Results In total, 1655 (32%) participants had AKI; 961 (58%), 223 (13%), and 270 (16%) met Kidney Disease Improving Global Outcomes definitions of stage 1, 2, and 3 AKI …
Importance Proton pump inhibitors (PPIs) are among the most commonly used drugs worldwide and have been linked to acute interstitial nephritis. Less is known about the …
M Baker, MA Perazella - American Journal of Kidney Diseases, 2020 - Elsevier
The management of pain in patients with chronic kidney disease (CKD) is challenging for many reasons. These patients have increased susceptibility to adverse drug effects due to …
ML Maes, DR Fixen… - Therapeutic advances in …, 2017 - journals.sagepub.com
Proton-pump inhibitors (PPIs) are a widely prescribed class of medications used to treat acid- related disorders and use has significantly increased over the last few decades. PPIs are …
T Antoniou, EM Macdonald, S Hollands… - … Open Access Journal, 2015 - cmajopen.ca
Background Proton pump inhibitors (PPIs) cause interstitial nephritis and are an underappreciated cause of acute kidney injury. We examined the risk of acute kidney injury …
S Nochaiwong, C Ruengorn, R Awiphan… - Nephrology Dialysis …, 2018 - academic.oup.com
Background Existing epidemiological studies illustrate that proton pump inhibitors (PPIs) may be related to adverse kidney outcomes. To date, no comprehensive meta-analysis has …